Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Immunotherapy
Chronic Lymphocytic Leukemia
Clinical Trials
Prostate Cancer
Colorectal Cancer
Breast Cancer
Non-Hodgkin Lymphoma
PARP Inhibitors
Antibody-Drug Conjugates
Venetoclax
BTK Inhibitors
Ovarian Cancer
Endometrial Cancer
Diffuse Large B-Cell Lymphoma
Circulating Tumor DNA
Follicular Lymphoma
Chemotherapy
CAR T-Cell Therapy
Gastroesophageal Cancer
Urothelial Bladder Cancer

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes525Founded6 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Featuring an interview with Dr L Elizabeth Budde, including the following topics:

• Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00)

• Management of BsAb-induced cytokine release syndr... more

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:

• Introduction (0:00)

• EGFR Mutations (2:23)

• HER2 Alterations (22:40)

• Available and Investigational Immunotherapi... more

YouTube

Featuring an interview with Dr Neeraj Agarwal, including the following topics:

• Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00)

• Approaches to monitoring for disease progression in patients who are PTEN def... more

YouTube

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:

• Case: A woman in her mid 60s with metastatic serous endometrial carcinoma that is HER2 IHC 3+ who r... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dr David Cescon
From Princess Margaret Cancer Centre, expert in breast cancer clinical trials and management.
Princess Margaret Cancer Centre, University of Toronto
Episode: Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 2 with Dr David W Cescon
Gottfried Konecny
Gynecologic oncologist, UCLA and David Geffen School of Medicine
University of California, Los Angeles; David Geffen School of Medicine
Episode: Gynecologic Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Fern Anari
Clinical investigator from Fox Chase Cancer Center
Fox Chase Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 7
Alexandra Drakaki
Clinical investigator from UCLA Health Johnson Comprehensive Cancer Center
UCLA Health
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 7
Jonathan Anker
Clinical investigator from Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 7
Aditya Bardia
Dr Aditya Bardia from UCLA Health Johnson Comprehensive Cancer Center
UCLA Health
Episode: Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Andreas Hochhaus
Professor from the Comprehensive Cancer Center, Central Germany, and Jena University Hospital
Comprehensive Cancer Center, Central Germany; Jena University Hospital, Germany
Episode: Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus
Solange Peters
Professor, Lausanne University Hospital
Lausanne University Hospital
Episode: Non-Small Cell Lung Cancer — Targeting KRAS G12C
Josh Sabari
Oncologist, Perlmutter Cancer Center and NYU Grossman School of Medicine
Perlmutter Cancer Center/NYU
Episode: Non-Small Cell Lung Cancer — Targeting KRAS G12C

Host

Neil Love
Host of the program; multiple instances across Oncology Today series

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#68
Saudi Arabia/Science
Apple Podcasts
#158
India/Science
Apple Podcasts
#171
Denmark/Science
Apple Podcasts
#215
Hong Kong/Science

Talking Points

Recent interactions between the hosts and their guests.

For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Q: How do you sequence the therapies among PI3K inhibitors vs AKT inhibitors in patients with PIC3CA mutations and prior CDK4/6 inhibitor exposure?
Many clinicians favor AKT inhibitors like capivasertib due to better tolerability, reserving PI3K inhibitors when a patient is more likely to benefit from direct tumor targeting, though head-to-head data are lacking; decisions still hinge on mutation status, prior therapies, and tolerance.
For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Q: For which patients are you prioritizing the triplet regimen of inovulisib-palbociclib-fulvestrin in the frontline setting?
The triplet is most attractive for very high-risk patients who have progressed on adjuvant endocrine therapy and have a PIC3CA mutation; however, real-world data will determine how broadly it should be used in frontline settings, particularly given evolving CDK4/6 inhibitor strategies.
Metastatic Bladder Cancer — Rapid Case Review Issue 8
Q: Any questions for the faculty?
The host prompts the faculty for discussion, and the panel focuses on diagnostic and management questions, including how to monitor disease burden with CT DNA and how diabetes status affects starting regimens.
AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Q: From a clinician's perspective, what is the single most common toxicity that affects adherence to capybara-certib?
Diarrhea is the most frequently problematic toxicity impacting adherence, and early proactive management is emphasized.
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 1 with Dr David W Cescon
Q: How does PD-L1 status influence first-line treatment decisions and the role of immunotherapy in combination with Trope II ADCs?
PD-L1 positivity ( CPS >10 ) identifies a subgroup where chemo-immunotherapy regimens show meaningful activity, and ongoing ASCENT04 and Tropion Breast 05 studies explore combinations with checkpoint inhibitors, suggesting a potential shift in practice for PD-L1 positive patients while Trope II ADCs remain superior to chemotherapy in broader comparisons.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

A clinically oriented show featuring medical oncologists and cancer researchers discussing new research, treatment strategies, and practical applications for general oncology practice. Episodes commonly center on hematologic and solid tumor malignancies, with deep dives into frontline versus relapse options, sequencing of therapies, adverse event management, and emerging modalities such as MRD-guided decisions, fixed-duration regimens, and novel agents (including BTK inhibitors, venetoclax-based regimens, HER2-targeted therapies, and cell/immune-based approaches). Guests frequently come from major academic centers and cancer institutes, bringing case-based perspectives, trial context, and real-world considerations to help practicing oncolog... more

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. Research To Practice | Oncology Videos
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Breast Cancer Update
5. OncLive® On Air

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 525 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Dr David Cescon
2. Gottfried Konecny
3. Fern Anari
4. Alexandra Drakaki
5. Jonathan Anker
6. Aditya Bardia
7. Andreas Hochhaus
8. Solange Peters

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days